Basis Medical announces successful first-in-human procedures using Seclusion catheter
Basis Medical has announced the successful completion of its first-in-human clinical procedures using the Seclusion catheter to treat chronic venous insufficiency (CVI) caused by...
Embolization receives US FDA 510(k) clearance for its NED embolisation device
Embolization recently announced it has recevied 510(k) clearance from the US Food and Drug Administration (FDA) for its Nitinol Enhanced Device (NED)—a vascular embolisation device intended for...
Endovascular Engineering’s ENGULF pivotal trial completes patient enrolment
Endovascular Engineering (E2) has completed patient enrolment in the pivotal cohort of its ENGULF trial, involving the Hēlo pulmonary embolism (PE) thrombectomy system.
The investigational...
Artificial intelligence tool predicts DVT risk following endovenous thermal ablation
A recent research article has detailed an artificial intelligence (AI) model that enables physicians to predict which patients with superficial venous insufficiency have a...
